Inhibition of p38alpha MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment.

Inhibition of p38alpha MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment.
复制标题

DOI:
10.1080/10428190802322919
复制
发表时间:
2008-10
影响因子:
2.6
通讯作者:
Kambhampati S
Kambhampati S
中科院分区:
医学4区
文献类型:
--
作者:
Navas T;Zhou L;Estes M;Haghnazari E;Nguyen AN;Mo Y;Pahanish P;Mohindru M;Cao T;Higgins LS;Platanias LC;List A;Verma A;Bhagat T;Gajavelli S;Kambhampati S

文献摘要

参考文献

被引文献

相似文献

Myelodysplastic syndromes (MDS) are common causes of ineffective hematopoiesis and cytopenias in the elderly. Various myelosuppressive and proinflammatory cytokines have been implicated in the high rates of apoptosis and hematopoietic suppression seen in MDS. We have previously shown that p38 MAPK is overactivated in MDS hematopoietic progenitors, which led to current clinical studies of the selective p38α inhibitor, SCIO-469, in this disease. We now demonstrate that the myelosuppressive cytokines TNFα and IL-1β are secreted by bone marrow (BM) cells in a p38 MAPK-dependent manner. Their secretion is stimulated by paracrine interactions between BM stromal and mononuclear cells and cytokine induction correlates with CD34+ stem cell apoptosis in an inflammation-simulated in vitro bone marrow microenvironment. Treatment with SCIO-469 inhibits TNF secretion in primary MDS bone marrow cells and protects cytogenetically normal progenitors from apoptosis ex vivo. Furthermore, p38 inhibition diminishes the expression of TNFα- or IL-1β-induced proinflammatory chemokines in BM stromal cells. These data indicate that p38 inhibition has anti-inflammatory effects on the bone marrow microenvironment that complements its cytoprotective effect on progenitor survival. These findings support clinical investigation of p38α as a potential therapeutic target in MDS and other related diseases characterized by inflammatory bone marrow failure.
DOI: 10.1200/jco.2004.07.131
发表时间: 2004-03-15
影响因子: 45.3
作者:
Devine, SM;Flomenberg, N;DiPersio, JF
通讯作者: DiPersio, JF
DOI: 10.1182/blood.v97.5.1427
发表时间: 2001-03-01
期刊: BLOOD
影响因子: 20.3
作者:
Bellamy, WT;Richter, L;List, AF
通讯作者: List, AF
DOI: 10.1126/science.1072682
发表时间: 2002-12-06
期刊: SCIENCE
影响因子: 56.9
作者:
Johnson, GL;Lapadat, R
通讯作者: Lapadat, R
DOI: 10.1016/0145-2126(95)00044-o
发表时间: 1995-09-01
期刊: LEUKEMIA RESEARCH
影响因子: 2.7
作者:
KOIKE, M;ISHIYAMA, T;TSURUOKA, NY
通讯作者: TSURUOKA, NY
DOI: 10.1182/blood.v89.6.2079
发表时间: 1997-03-15
期刊: BLOOD
影响因子: 20.3
作者:
Greenberg, P;Cox, C;Bennett, J
通讯作者: Bennett, J